First results from a randomized phase II study of cabazitaxel (CBZ) versus an androgen receptor targeted agent (ARTA) in patients with poor-prognosis castration-resistant prostate cancer (mCRPC). This ...
Represent 2 expressions using a see-saw. Tell whether 2 expressions are equal (balanced). Represent 10 using a number bond and 10-frame to help solve a Mystery Math Mistake. Use Notice and Wonder with ...
KEYNOTE-859: 4.5-year median follow-up of pembrolizumab plus chemotherapy for previously untreated advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results